Publication | Open Access
Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States
60
Citations
19
References
2021
Year
Administration of PCV20 in US infants was well tolerated, with a safety profile similar to PCV13, and induced robust serotype-specific immune responses. These findings support continued development of PCV20 in the pediatric population.
| Year | Citations | |
|---|---|---|
Page 1
Page 1